Amarin Corporation
AMRN
$0.93
Share price
1.08%
Change (1 day)
-34.19%
Change (1 year)
Categories
Amarin Corporation (AMRN) - Cash on Hand
Cash on Hand as of December 2023 : $0.32 B
According to Amarin Corporation
's latest financial reports the company has $0.32 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Amarin Corporation - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.32 B | 3.65% |
| 2022-12-31 | $0.30 B | -31.88% |
| 2021-12-31 | $0.45 B | -9.34% |
| 2020-12-31 | $0.50 B | -22.29% |
| 2019-12-31 | $0.64 B | 158.63% |
| 2018-12-31 | $0.24 B | 238.45% |
| 2017-12-31 | $73.63 M | -25.05% |
| 2016-12-31 | $98.25 M | -8.14% |
| 2015-12-31 | $0.10 B | -10.52% |
| 2014-12-31 | $0.11 B | -37.58% |
| 2013-12-31 | $0.19 B | -26.41% |
| 2012-12-31 | $0.26 B | 123.19% |
| 2011-12-31 | $0.11 B | 270.85% |
| 2010-12-31 | $31.44 M | -39.83% |
| 2009-12-31 | $52.25 M | 267.01% |
| 2008-12-31 | $14.23 M | -22.2% |
| 2007-12-31 | $18.3 M | -50.27% |
| 2006-12-31 | $36.8 M | 8.54% |
| 2005-12-31 | $33.9 M | 208.55% |
| 2004-12-31 | $10.98 M | 424.03% |
| 2003-12-31 | $2.09 M | -91.37% |
| 2002-12-31 | $24.28 M | -19.55% |
| 2001-12-31 | $30.19 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 AbbVie ABBV | $12.81 B | 3,896.77% | 🇺🇸 USA |
 AstraZeneca AZN | $8.02 B | 2,401.41% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $6.35 B | 1,881.80% | 🇬🇧 UK |
 Alkermes ALKS | $0.77 B | 141.22% | 🇮🇪 Ireland |
 Teva Pharmaceutical Industries TEVA | $3.22 B | 906.05% | 🇮🇱 Israel |